Hsp90 is an abundant molecular chaperone essential to the establishment of many cellular regulation and signal transduction systems, but remains one of the least well described chaperones. The biochemical mechanism of protein folding by Hsp90 is poorly understood, and the direct involvement of ATP has been particularly contentious. Here we demonstrate in vitro an inherent ATPase activity in both yeast Hsp90 and the Escherichia coli homologue HtpG, which is sensitive to inhibition by the Hsp90-specific antibiotic geldanamycin. Mutations of residues implicated in ATP binding and hydrolysis by structural studies abolish this ATPase activity in vitro and disrupt Hsp90 function in vivo. These results show that Hsp90 is directly ATP dependent in vivo, and suggest an ATP-coupled chaperone cycle for Hsp90-mediated protein folding.
Introduction
Despite their ubiquitous biological distribution and cellular abundance, the Hsp90 family of proteins remain amongst the least well understood of all the molecular chaperones. In eukaryotes, as well as playing a vital role in thermotolerance and stress responses, the cytoplasmic Hsp90s are essential for establishing the function of proteins involved in a wide range of cell regulation and signalling pathways, including steroid hormone receptors (Joab et al., 1984) , helix-loop-helix transcription factors (Wilhelmsson et al., 1990) , tyrosine and serine/threonine kinases (Opperman et al., 1981; Stancato et al., 1993; Aligue et al., 1994; Cutforth and Rubin, 1994; Dai et al., 1996) , and tumour suppressors (Chen et al., 1996; Sepehrnia et al., 1996) , amongst others. In vitro, purified Hsp90 binds to denatured protein and displays anti-aggregant properties (Wiech et al., 1992) . However, in vivo, Hsp90-dependent folding and activation of client proteins involves a plethora of accessory factors or co-chaperones which participate in multiprotein complexes with Hsp90. These include the ATP-dependent chaperone Hsp70/DnaK, and its cochaperones Hsp40/DnaJ (Kimura et al., 1995) and p48/ Hip (Hohfeld et al., 1995) which interact with Hsp90 via p60/Hop/Sti1 (Smith et al., 1993) . Other accessory factors are associated with particular subclasses of client proteins, so that Hsp90-steroid hormone receptor complexes also contain immunophilins such as cyclophilin 40 or FKBP59/ Hsp59 (Owens-Grillo et al., 1995) , whereas Hsp90-protein kinase complexes contain p50/CDC37 (Hunter and Poon, 1997) .
A clear understanding of the biochemistry of Hsp90 has been hampered by a controversy regarding the direct involvement of ATP in its mechanism of action. Thus, cytoplasmic and endoplasmic reticulum Hsp90s have been reported as highly active ATPases (Nadeau et al., 1992 (Nadeau et al., , 1993 or even GTPases (Nardai et al., 1996) that autophosphorylate (Csermely and Kahn, 1991; Csermely et al., 1995) , undergo conformational changes in the presence of ATP (Csermely et al., 1993; Sullivan et al., 1997) and require ATP for their interaction with co-chaperones Toft, 1994, 1995) and peptides (Li and Srivastava, 1993) . Conversely, Hsp90s purified from different sources lacked ATPase activity (Wiech et al., 1993; Scheibel et al., 1997) , and what ATPase and autophosphorylation activity could be obtained was attributable to contamination with trace amounts of the protein kinases which associate strongly with Hsp90s (Shi et al., 1994; Wearsch and Nicchitta, 1996) . The question appeared to be settled by a detailed side-by-side comparison of Hsp90 and the known ATP-dependent chaperone Hsp70, in which Hsp90 could not be affinity labelled by azido-ATP, retained on ATP agarose or enhance the fluorescense of an ADP derivative, in contrast to Hsp70 which could do all three (Jakob et al., 1996) . Subsequently, it has become generally accepted in the chaperone literature that Hsp90 is an ATP-independent chaperone (Buchner, 1996) , and observations of ATP dependence in Hsp90-dependent folding processes are attributed entirely to the ATPase activity of associated Hsp70 (e.g. see Schneider et al., 1996) .
The issue of ATP dependence in the mechanism of Hsp90 has re-emerged as a result of recent structural and biochemical studies (Grenert et al., 1997; Prodromou et al., 1997b; Scheibel et al., 1997) which have demonstrated the presence of an ADP/ATP-binding site in the N-terminal domain of Hsp90. This site is formed by motifs of the yeast Hsp90 polypeptide sequence, which are absolutely conserved in all Hsp90s and also occur in the N-terminal ATP-binding domains of type II DNA topoisomerases, and in MutL DNA mismatch repair proteins (Bergerat et al., 1997 ).
Here we demonstrate in vitro an inherent ATPase activity of Hsp90, which is sensitive to inhibition by the specific inhibitor geldanamycin and which is essential for the function of this molecular chaperone in vivo. These results suggest that protein folding mediated by Hsp90 operates via an 'active' ATP-coupled mechanism. (right) . The ligands are shown as space-filling models. Full details of the yeast Hsp90 N-terminal domaingeldanamycin complex will be published elsewhere, but the essential features of the complex are very similar to those described for the human Hsp90-geldanamycin complex (Stebbins et al., 1997) . Figures were generated using MOLSCRIPT (Kraulis, 1991) and Raster3D (Merrit and Murphy, 1994) .
Results

In vitro ATPase activity of Hsp90
The Saccharomyces cerevisiae Hsp90 isoform Hsp82, purified from an overproducing yeast strain to crystalline quality (Prodromou et al., 1996) , was assayed for ATPase activity using a sensitive coupled enzyme assay (see Materials and methods). The pyruvate kinase (PK)-lactate dehydrogenase (LDH) coupled assay converts any contaminating ADP to ATP prior to the addition of a putative ATPase. As ADP binds to the nucleotide-binding domain of Hsp90 with~5-fold greater affinity than ATP (Prodromou et al., 1997b) , its removal eliminates the possibility of ADP inhibition, which may have compromised other studies. At 37°C, which constitutes moderate heat-shock conditions for S.cerevisiae, we observed an ATPase activity for yeast Hsp90 of 5000 pmol/ min/mg corresponding to a k cat of 0.4/min, with a K M of 100 μM. At a normal growth temperature of 30°C, the activity was reduced by~4-fold, but was stimulated further at 43°C to nearly 1.0/min.
To demonstrate that the ATPase activity we observe is specific to Hsp90, and not due to contaminating protein kinases or other ATPases, we have taken advantage of the observation that the ATP-binding site in Hsp90 revealed by structural and biochemical studies (Grenert et al., 1997; Prodromou et al., 1997b) is also the binding site for the ansamycin antibiotic geldanamycin (Stebbins et al., 1997) (Figure 1 ). This compound binds to the yeast Hsp90 N-terminal domain with a K d of 0.5 μM, making specific interactions with many of the residues that interact with ATP, and is expected, therefore, to be a potent inhibitor of ATP binding. Addition of geldanamycin did not interfere with the function of the coupled enzyme assay, but effectively abolished the Hsp90-associated ATPase activity at a concentration of 15 μM (Figure 2 ).
We have also measured an ATPase activity (6500 pmol/min/mg equivalent to k cat 0.47/min at 37°C) in the Escherichia coli Hsp90 homologue HtpG, again purified to crystalline quality from an overexpressing E.coli strain. This activity was also sensitive to inhibition by geldanamycin, but was only slightly stimulated at 43°C. The presence of this activity in Hsp90 purified from entirely different backgrounds is further evidence that it is not an artefact due to a co-purified contaminant, and suggests that the ATPase activity is probably a general property of prokaryotic and eukaryotic Hsp90s. Although the turnover rates we observe for the inherent ATPase of Hsp90s are low by the standards of many ATPhydrolysing enzymes, they are of the same order of magnitude as the inherent ATPase activity of Hsp70s (O'Brien and McKay, 1995; Bukau and Horwich, 1998) . With Hsp70, the ATPase activity is markedly stimulated by client protein substrates and co-chaperones (Jordan and McMacken, 1995; McCarty et al., 1995; Theyssen et al., 1996) . It remains to be determined whether the ATPase activity of Hsp90 is modulated similarly by the presence of Hsp90-dependent client proteins, and/or by the cochaperones that are needed for Hsp90 action in both in vivo and in vitro reconstituted systems (Dittmar and Pratt, 1997) .
While this manuscript was in preparation, Scheibel et al. (1998) reported an ATPase activity in yeast Hsp90 which was also sensitive to inhibition by geldanamycin. However, the turnover reported in that study is only~20% of that we observe at 30°C. While we are not in a position to reconcile these differences, we note that that study utilized a radioactive non-regenerating assay, and may have been subject to inhibition by ADP (see above, and Materials and methods), which is inevitably present in such an assay.
In vivo ATP dependence
The existence of an inherent ATPase activity in Hsp90 suggests that many, if not all, of the biological functions of Hsp90 are directly ATP dependent. To test this hypothesis, we have determined the effect of mutations in residues implicated in ATPase activity on Hsp90 function in vivo. Saccharomyces cerevisiae has two genes for the Hsp90 protein, HSC82, which is constitutively expressed, and HSP82, which is normally expressed at a lower level than HSC82 but is strongly activated by heat shock. The encoded protein sequences are 97% identical. Deletion of either of these genes still produces viable cells, but deletion of both is lethal (Borkovich et al., 1989) . We constructed a haploid S.cerevisiae strain (PP30) that has the coding regions of both HSC82 and HSP82 completely deleted, but which is viable because it contains an episomal URA3 plasmid carrying a wild-type copy of HSC82 (see Materials and methods). Wild-type or mutant versions of an Hsp90-encoding gene can then be introduced on single-copy plasmids with LEU2 positive selection, and the functionality of the expressed Hsp90 protein determined by its ability to maintain cell viability when the URA3 plasmid that bears the wild-type HSC82 gene is deselected on 5-fluoro-orotic acid (5-FOA) plates.
From the crystal structures of the N-terminal domain of the yeast Hsp90 chaperone with bound nucleotides (Prodromou et al., 1997b) , we identified Asp79 as a key residue in adenine nucleotide binding. The carboxylate side chain of this residue makes a hydrogen bond to the exocyclic N6 group of adenine, thereby providing the only direct hydrogen bonding interaction between the protein and the base of the bound nucleotide. The hydrogenbonding environment of this residue is such that even a subtle mutation to asparagine would disfavour ATP binding by generating a strongly repulsive interaction with the adenine base, with minimal disruption of the structure in the nucleotide-binding site ( Figure 3 ). Furthermore, as this residue lies at the bottom of a deep pocket in the Hsp90 N-terminal domain structure, its mutation cannot directly affect interactions with other domains or associated proteins that are not mediated by a bound nucleotide. Structural homology between the Hsp90 N-terminal domain and the N-terminal ATPase domain of the DNA gyrase B protein (Gerloff et al., 1997; Prodromou et al., 1997b) aligns Glu33 of Hsp90 with Glu42 of gyrase B. Glu42 functions as a general base in the ATPase mechanism of DNA gyrase B , and mutation to alanine substantially reduces supercoiling and DNA-dependent ATPase activity, but does not prevent nucleotide binding . The structural homology between the ATP-binding sites in gyrase B and Hsp90 suggests that Glu33 might play a similar role in the ATPase activity of Hsp90. Thus, mutations of Asp79 and Glu33 would be expected to compromise Hsp90 function in vivo if ATP binding and hydrolysis are indeed essential.
HSP82 alleles with Asp79Asn, Asp79Arg, Asp79Trp and Glu33Ala mutations all failed to maintain yeast cell viability when the wild-type HSC82 gene was deselected on 5-FOA plates, whereas cells with the wild-type HSP82 remained perfectly viable ( Figure 4A and B). To verify that the targeted mutations were indeed responsible for the loss of viability, the mutant genes were reverted to wild-type by a second round of site-directed mutagenesis. All the reverted HSP82 alleles conferred full viability on 5-FOA plates. When co-expressed in the presence of wildtype HSC82, the mutant genes directed the synthesis of a full-length HSP82 product when induced by heat-shock, indicating that these mutations do not simply prevent expression of the protein ( Figure 4C) .
A functional HSC82 gene is sufficient to maintain viability in the presence of Asp79 or Glu33 mutant hsp82 alleles. However, these cells expressing both wild-type Hsc90 and a putative ATP binding-defective or ATPasedefective mutant Hsp90 grew less well than similar cells expressing Hsc90 and the wild-type Hsp90, indicating a probable semi-dominance of these Hsp90 mutations. To investigate this further, we constructed a variant of the PP30 strain (PP30a; see Materials and methods) in which Hsp90 function is provided by a HSP82 gene on the LEU2 plasmid pHSP82. Mutant or wild-type HSP82 alleles placed under control of the galactose-inducible GAL1 promoter were then introduced into this background on a URA3 plasmid, and their growth under inducing or non- inducing conditions compared. Relative to non-inducing conditions ( Figure 5A ), all strains harbouring a mutant hsp82 allele showed a marked retardation in growth on galactose substrates, a retardation not shown by isogenic cells expressing the wild-type Hsp90 protein ( Figure 5B and C). Thus the expression of mutant Hsp90s that have been shown in other experiments to be ATP bindingdefective or ATPase-defective (see below) is not neutral in vivo, but exerts strong dominant-negative effects on growth. We have not yet defined the mechanism of this semi-dominance, but it most likely arises through sequestration of essential client proteins and/or cochaperones into complexes with these inactive Hsp90 dimers, which are then unable to progress through folding. Whether heterodimers between wild-type and defective mutants are also inactive remains to be seen.
In vitro analysis of ATP-binding site mutations
From the roles ascribed to Glu33 and Asp79 by the structural data, and by analogy with the homologous residues in DNA gyrase , mutants of the catalytic residue Glu33 would be expected to bind adenine nucleotides, whereas mutants of Asp79 would not. To verify that the observed functional defects of mutations of these residues in vivo was consistent with their predicted biochemical roles, the N-terminal domains for the Asp79Asn and Glu33Ala mutants were assayed for ADP and ATP binding using isothermal titration calorimetry, as described previously for the wild-type domain (Prodromou et al., 1997b ; see Materials and methods). The Asp79Asn mutant N-terminal domain bound neither ATP nor ADP to any measurable extent, in contrast to the Glu33Ala mutant which retained affinity for ATP comparable with that previously described for the wild-type domain (Prodromou et al., 1997b) . Although ATP binding by the N-terminal domain was largely unaffected, the Glu33Ala mutation reduced the ATPase activity of the intact protein to Ͻ1% of the level observed for the wild-type. Finally, to verify that the loss of adenine nucleotide binding by the Asp79Asn mutant was due to the local changes in hydrogen bonding possibilities at the bottom of the nucleotide-binding pocket, and not to gross misfolding of the protein as a result of the mutation, the N-terminal domain of the Asp79Asn mutant was crystallized as described previously for the wild-type protein (Prodromou et al., 1996) and the structure determined at 2.1 Å resolution. Comparison of the refined Asp79Asn mutant N-terminal domain structure with that of the wild-type chaperone gives a root-mean-square difference between all protein atoms of only 0.9 Å, which indicates that the overall structures are effectively identical within the limits of the method, and have not been altered significantly by the Asp to Asn mutation.
Discussion
The presence of a specific ATPase activity inherent in Hsp90, and the failure of the Hsp90 mutants defective in ATP binding and hydrolysis in vitro to maintain cell viability, demonstrates unambiguously the direct ATP dependence of Hsp90 function in vivo. All the residues implicated in ATP binding and hydrolysis from structural studies (Prodromou et al., 1997b) are absolutely conserved in the known amino acid sequences of the cytosolic Hsp90 and endoplasmic reticulum GRP94 of eukaryotes, and in the HtpG of bacteria, suggesting that ATP dependence is a universal property of the Hsp90 family of molecular chaperones.
A variety of temperature-sensitive mutants of yeast Hsp90 have been identified (Nathan and Lindquist, 1995) , some of which correspond to missense mutations within the N-terminal domain of the protein. One of these mutations, Ala41Val, affects a residue which forms part of the hydrophobic binding site for the adenine base of 4833 ATP (Prodromou et al., 1997b) . Mutation to the larger side chain of valine would be expected to constrict the adenine-binding site and decrease the affinity of Hsp90 for ATP. While this mutant only shows mild growth retardation at permissive temperatures, its complete loss of viability at non-permissive temperatures could indicate that ATP binding and hydrolysis are of increased importance to the cellular function of Hsp90 during heat shock. Characterization of ATP binding and hydrolysis by this and other temperature-sensitive mutants is in progress.
Previous in vitro studies have shown that isolated Hsp90 displays an apparently ATP-independent chaperone activity in vitro, binding denatured proteins and thereby contributing to their renaturation by preventing their aggregation (Wiech et al., 1992; Jakob et al., 1995; Yonehara et al., 1996) . Although these studies have been conducted with proteins not known to be dependent on Hsp90 for their folding in vivo, and in the absence of the various co-chaperones with which Hsp90 is known to be functionally associated in vivo, the lack of a requirement for ATP in this in vitro chaperone activity would appear to be in conflict with the ATP dependence of Hsp90 activity in vivo that we describe here.
A resolution of this apparent paradox comes from a reassessment of studies of the action of ansamycin antibiotics on Hsp90-mediated protein folding. Geldanamycin and the closely related herbimycin-A have been shown to interfere with the folding and activation of a range of client proteins by Hsp90 (e.g. Whitesell and Cook, 1996; Stancato et al., 1997) and thereby promote their degradation (Schneider et al., 1996; Whitesell et al., 1997) . Significantly, inhibition of Hsp90-mediated protein folding by geldanamycin does not block formation of Hsp90 complexes with incompletely folded or denatured client proteins (Smith et al., 1995; Dittmar and Pratt, 1997) , nor does it disrupt existing Hsp90-client complexes (Chen et al., 1997; Dasgupta and Momand, 1997) , but rather stabilizes them, leaving unfolded protein associated with Hsp90 and unable to progress through folding (Schneider et al., 1996) . Given that geldanamycin binds to the same site on Hsp90 as ATP (Grenert et al., 1997; Prodromou et al., 1997b) and inhibits the ATPase activity of Hsp90 (see above), these observed effects of ansamycins are most consistent with the inhibition of a directly ATPdependent step in Hsp90-mediated protein folding, occurring after incompletely folded proteins have bound to Hsp90. Thus, the ATP-independent 'passive' chaperone activity of Hsp90 observed in vitro, and previously presented as the sum-total of its activity as a molecular chaperone (Buchner, 1996) , may instead represent just the first step in an active, and ATP-dependent mechanism in vivo. This does not eliminate the possibility that for some proteins, a passive anti-aggregant interaction with Hsp90 in vivo, as with citrate synthase and β-galactosidase in vitro (Jakob et al., 1995; Freeman and Morimoto, 1996) , may be sufficient to facilitate folding. However, that the Hsp90-dependent folding of many cell regulatory and signal transduction proteins is blocked by geldanamycin argues strongly that these most biologically significant client proteins demand an active and ATP-dependent chaperone activity of Hsp90.
Direct functional dependence on binding and hydrolysis of ATP moves Hsp90 into the class of 'active' chaperones typified by Hsp70/DnaK and Hsp60/GroEL, and prompts consideration of functional analogies to these comparatively well-characterized systems. While Hsp60 and Hsp70 themselves are substantially different in their structures and in their mode of interaction with protein substrates, they both utilize ATP in essentially similar ways. Thus both systems are switched between an ATP-bound conformational state with low affinity for substrate proteins and an ADP-bound conformational state with high affinity for substrate, by cycles of ATP binding, ATP hydrolysis and ADP release (Bukau and Horwich, 1998) . With Hsp90, there is clear evidence for both binding (Grenert et al., 1997; Prodromou et al., 1997b; Scheibel et al., 1997) and now hydrolysis of ATP. In type II DNA topisomerases, ATP binding and hydrolysis by the homologue of the Hsp90 N-terminal domain provides an ATP-driven motor for the conformational changes accompanying DNA relaxation (Bates and Maxwell, 1997) . ATP-induced conformational changes have been reported for Hsp90 (Csermely et al., 1993; Sullivan et al., 1997) . The molecular nature of these ATP-dependent conformational changes in Hsp90 are unknown; however, the ATP-bound state appears to display the significantly decreased hydrophobicity (Sullivan et al., 1997) that would be consistent with the low affinity for substrates observed in the ATPbound states of Hsp60/GroEL and Hsp70/DnaK chaperones. Thus, there is at least a prima facie case for a chaperone cycle in Hsp90. The key questions of how binding and hydrolysis of ATP are coupled to conformational changes in Hsp90, how these facilitate protein folding and what roles are played by the various cochaperones are yet to be answered.
Materials and methods
Strains and plasmids
The S.cerevisiae strain PP30 (a, 112, hsc82KANMX4, hsp82KANMX4 ) was used as the host strain for expression of HSP82 mutant alleles. Its essential Hsp90 function is provided by the HSC82 gene of the plasmid pHSC82, a vector derived by cloning the 5.5 kb BamHI fragment from pUTX203 (Borkovich et al., 1989) into the URA3 vector pYEplac195 (Gietz and Sugino, 1988) . Plasmid pHSP82 was obtained by cloning the 2.5 kb BamHI HSP82 fragment from p82-2B (Cheng et al., 1992) into the centromeric LEU2 vector pYCplac111 (Gietz and Sugino, 1988) . To generate strain PP30(a), which expresses HSP82 only, PP30 was transformed with pHSP82, followed by curing for pHSC82 by streaking a transformant on drop-out media without leucine, but containing 5-FOA (0.1%).
Mutagenesis and plasmid construction
Single amino acid changes were generated in the HSP82 gene of pHSP82 using the QuickChange site-directed mutagenesis kit (Stratagene). The following mutations were introduced and confirmed by sequencing: Asp79Asn, Asp79Arg, Asp79Trp (GAT to AAC, TGG and AGA, respectively) and Glu33Ala (GAA to GCT). Mutants were reverted to wild-type by a second round of mutagenesis, and their ability to support yeast cell viability as the only Hsp90 present was tested in order to verify that the desired mutation was the only change present in each gene. Mutations were confirmed by dye terminator cycle sequencing (ABI).
To illustrate clearly a semi-dominant phenotype, the wild-type and mutant alleles of HSP82 were placed under the control of an inducible promoter. Alleles were PCR amplified using pHSP82 (or Asp79Asn, Asp79Trp, Asp79Arg and Glu33Ala mutants) and inserted into pYES2 with URA3 selection for expression under control of the inducible GAL1 promoter of S.cerevisiae.
For expression of yeast HSP82 mutants in E.coli, the coding sequences were PCR amplified from the yeast pHSP82 plasmids and inserted into pRSETA, for expression of an N-terminally fused His 6 -tagged protein.
Media and genetic techniques
The S.cerevisiae strain PP30 was transformed with single or multicopy vectors bearing wild-type or mutant HSP82 (Ito et al., 1983) . Transformants were selected on drop-out media (Rose et al., 1990) without uracil and leucine. The ability of HSP82 mutants to maintain cell viability was assessed by streaking the transformants on drop-out media without leucine, but containing uracil (50 mg/ml) and 5-FOA (0.1%).
For semi-dominance studies, S.cerevisiae strain PP30(a) was transformed with pYES2 bearing the wild-type or mutant alleles of HSP82. Transformants were maintained on drop-out media without leucine or uracil. Transcription of HSP82 alleles on pYES2 was induced by streaking cells onto drop-out media without leucine or uracil containing galactose as the sole carbon source.
Radioactive labelling, production of cell extracts and fluorography Expression of Hsp90 was visualized by pulse labelling yeast cultures with 15 μCi/ml of Trans 35 S-label (ICN). Cultures growing exponentially at 28°C were shifted to 40°C heat shock for 10 min, and then labelled for 50 min. Quantification of radioisotope incorporation by scintillation counting was carried out as described previously (Panaretou and Piper, 1990) . Radiolabelled protein was visualized by SDS-PAGE on 7% gels, followed by fluorography (Chamberlain, 1979) .
Expression, purification and crystallization of mutants
Expression, purification and crystallization of the mutant N-terminal domains was as described previously for the wild-type protein (Prodromou et al., 1996 (Prodromou et al., , 1997a except for the following modifications. Protein was purified by loading a 60 ml nickel affinity column in 20 mM Tris-HCl pH 8.0 containing 500 mM NaCl (buffer A). The column was then washed with buffer A containing 50 mM imidazole pH 8.0, and mutant N-terminal domain eluted from the column with buffer A containing 300 mM imidazole pH 7.0. The protein was subsequently concentrated by an 80% (NH 4 ) 2 SO 4 precipitation and purified further using Superdex 75 gel filtration chromatography. Finally, the sample was concentrated by a second (NH 4 ) 2 SO 4 precipitation, dialysed against 3ϫ5 l of 20 mM Tris-HCl pH 7.4 and then concentrated to 40-50 mg/ml using an Amicon centriplus concentrator. Tetragonal bipyramidal crystals similar to those of the native N-terminal domain of Hsp90 (Prodromou et al., 1997a) were grown by vapour diffusion in hanging drops with the Asp79Asn mutant. Protein droplets contained 32.5 mM sodium succinate pH 5, 20 mM Tris-HCl pH 7.4, 65 mM (NH 4 ) 2 SO 4 , 9.75% PEGME 550 and 32 mg/ml protein. Crystallographic data sets were collected at 100 K on a Rigaku/MAR system with CuK radiation, and processed and refined as described previously (Prodromou et al., 1996 (Prodromou et al., , 1997a .
Hsp90-E33A mutant was expressed from the vector pRSETA in E.coli strain BL21(DE3)plysS under control of an isopropyl-β-D-thiogalactopyranoside (IPTG)-inducible T7 promoter. Cells were harvested 3 h after induction with 1 mM IPTG, and resuspended in 20 mM Tris pH 7.4 containing 1 mM EDTA, 1 mM dithiothreitol (DTT), 15% glycerol. Following disruption in the presence of protease inhibitors (Boehringer Mannheim), the clarified supernatant was subjected to ion exchange chromatography using Q-Sepharose and eluted with an NaCl gradient. After concentration on an XM50 membrane (Amicon), the protein was loaded onto a Sephacryl 400 HR gel filtration column equilibrated in 20 mM Tris pH 8.0 containing 500 mM NaCl and protease inhibitors. Fractions containing Hsp90E33A were pooled and diluted with 20 mM Tris pH 8.0 to reduce the NaCl concentration to 100 mM and applied to a Talon (Clontech) column equilibrated with 20 mM Tris pH 8.0 and 100 mM NaCl (buffer A). The column was washed with buffer A containing 10 mM imidazole and mutant protein eluted with buffer A containing 600 mM imidazole. The protein subsequently was dialysed against 3ϫ5 l of 20 mM Tris 7.4 and 1 mM EDTA prior to concentrating to 15.7 mg/ml.
Isothermal titration calorimetry (ITC) of nucleotide binding
The titration experiments were performed using the MSC system (MicroCal Inc., MA). In each experiment, 16 aliquots of 15 μl of 1 mM ATP or ADP were injected into 1.3 ml of N-terminal Hsp90 at 100 μM at 25°C, and the resulting data were fit after subtracting the heats of dilution as described previously (Prodromou et al., 1997b) . Heats of dilution were determined in separate experiments from addition of ATP or ADP into buffer and buffer into protein. Titration data were fit using a non-linear least squares curve-fitting algorithm with three floating variables: stoichiometry, binding constant (K b ϭ 1/K d ) and change of enthalpy of interaction (ΔH 0 ). Dissociation constants estimated for ATP binding are: K d ϭ 97 Ϯ 14 μM for the wild-type N-terminal domain, and K d ϭ 143 Ϯ 75 μM for the Glu33Ala mutant N-terminal domain. These affinities are close to the limit for ITC and consequently have large apparent errors of measurement. Binding to the Asp79Asn mutant was undetectable.
ATPase assay
The ATPase assay was based on a regenerating coupled enzyme assay (Ali et al., 1993) , in which the phosphorylation of ADP by PK at the expense of phosphoenol pyruvate is coupled to the reduction of the resulting pyruvate by LDH at the expense of NADH. Oxidation of NADH to NAD ϩ produces a loss of optical density at the NADH absorbance maximum of 340 nm, in direct stoichiometry to the amount of ADP phosphorylated. Each 1 ml assay contained 100 mM Tris-HCl pH 7.4, 20 mM KCl, 6 mM MgCl 2 , 0.8 mM ATP (Sigma), 0.1 mM NADH (Boehringer Mannheim), 2 mM phosphoenol pyruvate (Boehringer Mannheim), 0.2 mg of PK (Boehringer Mannheim), 0.05 mg of L-LDH (Boehringer Mannheim) and between 2 and 3.5 nmol of Hsp90 or HtpG. For the E33A mutant Hsp90, 20 nmol were used in each assay. Sufficient NADH was added to give an initial absorbance of 0.3 at 340 nm prior to addition of Hsp90s or fragments, and activity was detected as a decrease in absorbance. Inhibition of ATPase activity by geldanamycin was achieved by the addition of 1-10 μl of geldanamycin dissolved in dimethylsulfoxide (DMSO) to a final concentration of 1.5, 9, 15 and 30 μM geldanamycin. In control experiments, 1% DMSO present alone did not affect the measured ATPase activities, and stoichiometric rephosphorylation of ADP directly added to the assay system was unaffected by 1% DMSO or geldanamycin at the maximal concentration used. Geldanamycin was kindly provided by the Drug Synthesis and Chemistry Branch, National Cancer Institute, Bethesda, MD. All measurements were made on a Shimadzu UV-240 spectrophotometer.
